pertension and prevent its future development. However, raised ICP is recognized to occur in syndromic craniosynostosis following aesthetically successful corrective surgery and has been reported following variants of vertex strip craniectomy in isolated SC. 1, 24, 32, 47 Because the clinical symptoms and signs and radiological findings typically associated with intracranial hypertension are not reliable indicators of its presence in craniosynostosis, it is probable that the true incidence of postoperative raised ICP in SC is underestimated. 11, 45, 46 It is also unclear as to whether the rates of postoperative intracranial hypertension reported in the literature are specific to the surgical procedure used or are dependent on other factors.
To answer these questions we performed a retrospective study in a large cohort of patients with long-term follow-up who had been treated for SC. Importantly, patients were regularly reviewed by a multidisciplinary team with a high index of suspicion for intracranial hypertension and a low threshold for performing intraparenchymal ICP monitoring. This approach was followed in an attempt to identify all those who had developed raised ICP.
methods study Population
A retrospective review was performed of the medical records of all patients presenting with primary isolated SC to the Oxford Craniofacial Unit between January 1995 and December 2010. Patients were included in this study if they had undergone their primary corrective procedure under the care of the Oxford Craniofacial Unit and had been reviewed for a minimum of 2 years following surgery. Patients were specifically excluded if it was discovered on preoperative imaging or at the time of surgery that they had synostosis of another cranial suture in addition to the sagittal suture or, following review by a clinical geneticist specialist, were identified to have a known genetic mutation associated with craniosynostosis on genetic screening, either prior to surgery or subsequently. Those with SC considered to be secondary to perinatal intraventricular hemorrhage, hydrocephalus, or CSF shunting procedures were also excluded.
operative Procedures
Patients underwent 1 of 2 primary procedures during this period. Until 2007, patients who presented at less than 6 months of age underwent a modified sagittal strip craniectomy (MSC). A wide sagittal strip craniectomy was performed, removing a 5-to 8-cm broad strip of the calvaria centered on the sagittal suture extending from the coronal to lambdoid sutures, with or without the addition of lateral barrel staving (Fig. 1) .
Patients who were older at presentation underwent a 5-panel total calvarial remodeling (CR) procedure, referred to as the lateral switch rotation technique. In brief, temporoparietal panels are elevated and interlocking osteotomies performed to permit lateral expansion. The panels are then either rotated through 180° in situ or switched from side to side to correct for temporal pinching. The frontal and occipital panels are raised and a crescentshaped strip is excised from their inferior margins to recess the panels, correcting for bossing. The panels are widened by barrel staving. All 4 panels are secured to the skull base with stainless steel wire. The vertex panel is divided, and together with bone fragments created in the shaping of the other panels, placed, without fixation, to cover the vertex expansion gap. These bone pieces are retained in position beneath a pericranial flap (Fig. 2) .
Patients with a milder deformity underwent subtotal CR in which the frontal panel, occipital panel, or both panels were left in situ and flared supralaterally through barrel staving. Panels were left in situ when the deformity affecting that area was judged to be sufficiently mild so as not to warrant correction.
From 2007 MSC was increasingly rarely performed, due to a higher rate of revision surgery in these patients. Instead, children were treated with CR at 12 months of age. The last MSC was performed in 2010. 
Follow-up
Following discharge patients were reviewed at 3-6 months, then approximately yearly to the age of 10 years, after which they were evaluated on a biannual basis until skeletal maturity. Those patients whose progress raised concerns were followed up on a more frequent basis. All patients were repeatedly reviewed by a multidisciplinary team that included the operative surgeons, a clinical psychologist, an orthoptist (with ophthalmological support), and speech and language therapists. Patients were specifically assessed with regard to the possible presence of raised ICP.
Symptoms considered suggestive of raised ICP included: persistent early morning or nocturnal headaches that awoke a child from sleep; sleep disturbance; nausea or vomiting, especially in conjunction with nocturnal headaches; irritability manifesting as a short attention span, violent outbursts, declining academic performance, and sociability; new onset psychomotor delay not attributable to other causes; deteriorating gait; persistent lethargy; and seizures. In those patients in whom these symptoms were new in onset and other potential causative factors had been excluded, the children were closely followed up for between 3 and 6 months. Follow-up might be extended further if the symptoms were sufficiently mild. If the symptoms persisted or deteriorated over this period, a CT scan with 3D reconstruction of the head was performed.
Signs suggestive of raised ICP were also sought in patients presenting with the symptoms described above. All patients underwent funduscopy, and when papilledema was identified, a CT scan was arranged immediately. Patients who experienced an abnormal cessation of head growth (a "plateau" in head circumference) or who developed an abnormal cranial morphology (including a scaphocephalic relapse, vertex bulge, turricephaly, brachycephaly, or frontal plagiocephaly) were considered likely to be at higher risk of raised ICP. When these morphological abnormalities were present in conjunction with newonset symptoms, CT was expedited. Occasionally CT was performed when morphological deterioration was severe, even in the absence of symptoms.
The CT scans were reported by consultant neuroradiologists with a specialist interest in craniosynostosis and then discussed with a consultant surgical craniofacial team, consisting of pediatric neurosurgeons and plastic and reconstructive surgeons. New radiological signs were considered to be suggestive of raised ICP, including a beaten-copper pattern of the calvaria, reduced extraaxial space, or ventricular effacement. If these were present and believed to be consistent with the clinical symptoms and signs that the patient had manifest, formal ICP monitoring was organized.
Monitoring was conducted over a 24-to 48-hour period using an intraparenchymal Codman microsensor (Codman Microsensor, Johnson & Johnson Professional Inc.) placed in the right or left frontal lobe under a general anesthetic. A baseline consistently above 15 mm Hg or more than 3 B-waves in a 24-hour period was considered to be indicative of raised ICP. 50 Children with raised ICP underwent calvarial expansion by either lateral panel release or subtotal CR. The patients were closely monitored in situations in which the ICP was considered to be borderline. Further intraparenchymal monitoring was performed at a later date depending on subsequent clinical and radiological findings. All children who underwent repeat transcranial surgery for raised ICP or another indication were reviewed by a clinical geneticist specialist and underwent genetic screening. This study, as a retrospective audit, was performed in compliance with local Institutional Review Board regulations.
statistical analysis
Statistical analysis was performed using the Stata statis- 
results
In total, 217 patients (164 boys and 53 girls) underwent either MSC (n = 89) or CR (n = 128) for primary isolated SC (Table 1) . A further 19 patients who had surgery during the study period and otherwise met inclusion criteria were excluded because they did not complete more than 2 years of follow-up. Five patients had their care transferred to another center (4 after MSC, 1 after CR) and 1 died (after CR). The remainder, all of whom underwent CR, continue to be followed up but have yet to attend an outpatient appointment beyond 24 months after their primary procedure.
The 217 patients were followed up for a mean of 86 months (range 24-212 months). MSC-treated infants had surgery at a median of 6.0 months of age (mean 6.0 ± 1.4 months, range 2.5-9.5 months; 
icP monitoring
In the group treated using CR, 21 children had ICP monitoring prior to surgery as part of a standard management protocol. ICP monitoring was considered in all patients in whom nonoperative management was proposed or when parents were reluctant to agree to corrective surgery. Children who had ICP monitoring were older on average (mean 66.0 ± 30. In total, 43 patients (19.8%) had ICP monitoring following primary surgery. Eight presented during follow-up with new symptoms, clinical signs, and radiological signs consistent with raised ICP, 22 had symptoms and radiological signs only, while 7 had symptoms alone ( Table 2 ). The final 6 patients did not present with symptoms but had a significant deterioration in their calvarial shape and signs suggestive of raised ICP on CT. Of the group of 43 patients as a whole, 11 (25.6%) were found to have raised ICP on monitoring.
Twelve patients who did not have raised ICP at their first monitoring procedure subsequently developed new symptoms, or clinical or radiological signs (Table 2) , which resulted in these patients undergoing a further ICP monitoring procedure at a mean of 28 months later (range 7-110 months). Four patients (33.4%) were found to have raised ICP on their second ICP monitoring procedure. Two patients had a third monitoring procedure for further symptoms. Neither was found to have raised ICP.
Although all patients who had ICP monitoring presented with new symptoms or signs indicative of raised ICP, no particular symptom or clinical sign was more closely correlated with the presence of raised ICP on subsequent monitoring (Table 3) . Similarly, although patients were usually required to have both positive clinical and radiological findings before undergoing ICP monitoring, no 1 radiological sign correlated better with a later finding of raised ICP than any other (Table 3 ). Furthermore, in the 8 instances in which ICP monitoring was performed because of highly suggestive clinical symptoms despite a lack of new radiological signs, an elevated ICP was found in only 2 of those children.
A primary Type I Chiari malformation was an incidental finding in 3 patients with suspected raised ICP. In all patients the malformation was present on initial imaging and had not progressed since. It was not considered to be a sign of raised ICP. All 3 children proved to have a normal ICP on monitoring. Of all the ICP monitoring procedures performed, only 1 was abandoned without a usable record following probe malfunction shortly after insertion. The patient underwent a repeat ICP monitor insertion the following day, which proceeded without incident.
elevated icP
In total, 15 patients proved to have an elevated ICP on monitoring (Table 4 ). This elevated ICP was diagnosed at a mean age of 60 months, at a mean interval of 51 months after primary surgery (range 23-100 months). The age of the patients, and the interval following surgery at which patients who were found to have a normal ICP underwent monitoring, were very similar to that for children with raised ICP. These patients with proven raised ICP underwent a CR or expansion procedure (Table 4) . A further 5 patients underwent a secondary CR procedure to correct a poor morphological outcome. Two of these patients had undergone postoperative ICP monitoring, which was normal in 1 patient and borderline in the other. One other child required the repair of a persistent calvarial vertex defect 9 years after their primary MSC. All 6 patients who had a secondary procedure for an indication other than raised ICP had a primary MSC. Overall, 19 (21.3%) of 89 MSC patients underwent a second unplanned transcranial procedure, while only 2 (1.6%) of 128 CR patients did, excluding ICP monitoring procedures (p < 0.0001, Fisher exact test).
Significant intraoperative venous sinus hemorrhages occurred in 2 MSC patients (2.2%; all in the sagittal sinus) and 6 CR patients (4.7%; 3 in the sagittal sinus, 2 in the superior petrosal sinus, and 1 in the transverse sinus). In addition, 6 CR patients (4.6%) experienced intraoperative subdural hemorrhages that required a durotomy for control. Clinically insignificant dural breaches also occurred more frequently during CR procedures.
Predictors of raised icP
Unadjusted Cox regression models showed that patients treated by MSC were at increased risk of raised ICP following surgery (hazard ratio [HR] 6.1, 95% CI 1.4-27.1; Table 5 ). Overall 13 MSC-treated patients (14.6%) developed raised ICP, while only 2 patients (1.6%) treated by CR did. Both CR-treated patients had a subtotal CR. There was also an effect of age at time of surgery, with patients older than 12 months having a lower risk of raised ICP (p = 0.01). Patients undergoing MSC had a longer follow-up period than CR-treated children. Therefore, a sensitivity analysis including only patients operated on prior to 2005 was performed to ensure patients in both surgical groups had adequate follow-up time to allow for the development of raised ICP. After this analysis, the findings remained unchanged for the comparisons of MSC versus CR (HR = 6.4, 95% CI 0.83-49.9; p = 0.075) and age > 18 months versus < 6 months (HR 0.12, 95% CI 0.02-0.96; p = 0.046).
Given the high correlation between age at surgery and type of procedure, it is not possible statistically to reliably determine which factor is causal in relation to raised ICP. However, all children older than 12 months at the time of surgery only underwent CR, and this group had a significantly lower risk of raised ICP. Furthermore, no child older than 18 months at surgery developed raised ICP. Also, no children with proven raised ICP prior to surgery, all of whom were then treated by CR, were found to develop it subsequently, despite the fact that 7 (46.7%) of these 15 patients had ICP monitoring after surgery.
Within the MSC group, the age at operation of patients who later developed raised ICP (mean 6.0 ± 1.4 months, median 5.6 months) was almost identical to that of children who did not (mean 6.0 ± 1.4 months, median 6.0 months), suggesting that age at surgery was not a significant factor within that group. In the CR group, the age at operation of the 2 patients who developed raised ICP was 11.6 months and 14.5 months. These ages were lower than the mean (27.0 ± 23.3 months) and median (17.1 months) of the rest of the group, but were not significantly different (Mann-Whitney U-test, p = 0.17). Thus, age at operation may possibly be a significant factor in CR-treated patients.
Regression modeling showed that there was no significant difference in ICP monitoring rates between the MSC-and CR-treated groups (HR 1.7, 95% CI 0.9-3.3; p = 0.083). However, patients treated by total CR did require monitoring less often than either MSC (HR 5.7, 95% CI 1.3-24.0; p = 0.018) or subtotal CR-treated patients (HR 5.2, 95% CI 1.2-22.9; p = 0.031). While more MSC-treated patients eventually experienced raised ICP, many fewer subtotal CR-treated patients did. The effect of high levels of monitoring in subtotal CR-treated patients remained significant after adjusting for age at operation. All patients who had raised ICP before surgery and had ICP monitoring following surgery were treated by subtotal CR. No other factors proved to be significant predictors of postoperative raised ICP.
discussion
The overall incidence of raised ICP following corrective surgery for SC in this study was 6.9%; among MSCtreated patients the rate was 14.6%. This is higher than the 1.4%-3.8% rate reported in other series of patients undergoing strip craniectomy. 1, 47 However, the manner in which patients with potentially raised ICP were identified differs between this study and the others. In the series of Adamo and Pollack, 2 patients underwent further surgery, having both presented with papilledema.
1 In 1 case this was associated with restricted head growth and in the other, new-onset bicoronal craniosynostosis. Both patients had an elevated ICP on lumbar puncture.
In our series, 20 patients manifested worsening head shape as one of their presenting features, of whom 7 had raised ICP. Interestingly, the 2 patients who developed secondary synostosis of previously uninvolved coronal sutures (right and bicoronal) both had an elevated ICP.
In the series of van Veelan and colleagues, 6 patients were found to have papilledema, 3 of whom were found to have raised ICP. 47 Papilledema is a relatively late sign of low sensitivity in children younger than 8 years old. 45 In our patient series only 1 child had papilledema, because we believe a vigilant follow-up protocol was able to identify cases with raised ICP before papilledema developed. In a smaller series of 47 patients with SC, Cetas and colleagues reported postoperative raised ICP in 5 patients (10.5%), 2 of whom had strip craniectomies with barrel staving and 3 an anterior two-thirds cranial vault reconstruction. 8 This rate more closely reflects that of this series. All of their patients presented with symptoms of raised ICP and 3 had papilledema. Interestingly, all 5 were found to have secondary unicoronal or bicoronal synostosis. They also report that all patients showed a decreasing velocity of head growth relative to the normal population, with percentiles for head circumference decreasing between their first and second procedures. The clinical significance of this finding is questionable, as the phenomena of postsurgical decline in relative head circumference in SC is well recognized and widespread; 12, 44, 47 it is therefore probably unlikely to have a specific etiological role in the development of raised ICP.
In our study, patients only underwent ICP monitoring if the exhibited symptoms or signs of raised ICP and, in the majority, had corresponding radiological signs. However, within this group of children, no single or combination of symptoms, clinical signs, or radiological findings were significantly more likely to herald raised ICP. Eide and colleagues, in a large series of 121 children, reported that there was little correlation between particular clinical symptoms and an abnormal ICP. 11 We suspect that this is because the typical symptoms of elevated ICP, including headaches and irritability, have a number of potential causes in children with craniosynostosis, and are therefore poorly specific. Likewise, although a beaten-copper appearance of the calvaria on radiological imaging has long been associated with raised ICP, it is common following surgery for SC, and increases in incidence with patient age. 4, 46 Similarly, reduction of the extraaxial space on CT, manifesting as effacement of the sulci and loss of the subarachnoid space, is more common in children with raised ICP, but is also present in those with normal pressures. 46 Furthermore, the identification of 2 patients with abnormal ICP but no corresponding signs on CT underscores the point made by Tuite and colleagues that radiological signs are neither specific nor sensitive in this regard. 46 We therefore conclude that once raised ICP is suspected, only formal monitoring can determine for certain whether it is present. We prefer to perform direct monitoring of ICP using an intraparenchymal Codman microsensor. Although this method requires a general anesthetic for probe placement, it has consistently proved to be a highly reliable and reproducible method of assessing ICP, with only an infrequent and minor complication rate associated with it. 11, 22, 33, 50 In this patient series, the only significant complication was probe malfunction, necessitating a repeat procedure. Our use of a threshold of more than 15 mm Hg to define an abnormally elevated ICP is consistent with that used by all previous studies that have undertaken overnight intracranial ICP monitoring in craniosynostosis, no matter whether an extradural or subdural device was employed. 6, 11, 13, 28, 35, 42, 43, 45, 46 The pathological significance of multiple B-type waves is also well recognized in the literature. 11, 35, 50 Consistent with the patient series of van Veelan et al. and Cetas et al., we found that elevated ICP was diagnosed late, at least 2 years after primary surgery, with a mean at just under 4.5 years of follow-up. 8, 47 This interval, along with the findings that only 1 patient had papilledema and that 4 children developed raised ICP on re-monitoring after a proven normal ICP, strongly suggests that the pathological rise in ICP we observed occurred after primary surgery. We have no evidence to indicate that an elevated ICP was present beforehand and persisted through the first corrective procedure to the time of diagnosis after surgery in any patients in this study. The insidious onset of raised ICP following corrective surgery underscores the need for prolonged, careful follow-up.
The pathological evolution of intracranial hypertension in CS is not well described, not least because, except in a handful of cases, it is treated when diagnosed. 6 A dearth of evidence of significant impairments due to raised ICP in patients re-presenting late after surgery would suggest that in SC it rarely reaches a catastrophic conclusion. However, raised ICP may well account for some of the subtle behavioral and developmental abnormalities encountered in SC, and prevent individuals from attaining their full intellectual potential. The extent to which raised ICP is responsible for these neurobehavioral abnormalities is contested.
14 Studies that infer that there is little or no relationship between the two often compare pre-and postoperative developmental outcomes or children that have or have not had surgery. 9, 20, 38, 39 The conclusions that these studies reach are in part based on the implicit assumption that early surgery corrects raised ICP where present and prevents its future occurrence. The data presented here contradict this assumption and suggest that any developmental or psychomotor assessment not accompanied by contemporary ICP measurements should be interpreted with caution.
In this study raised ICP was significantly more likely to be diagnosed following MSC than CR. Not only was raised ICP significantly less common following CR surgery, no patient with proven intracranial hypertension prior to surgery and treated by CR developed it subsequently. Patients with a preoperative diagnosis of raised ICP had ICP monitoring more frequently than others after surgery, as the multidisciplinary team had a lower threshold for monitoring in these patients.
We hypothesize that MSC inadequately decompresses the cranium and incompletely corrects the scaphocephalic deformity, failing to prevent raised ICP from developing in a minority of cases. Morphological outcome studies indicate that variants of open vertex strip craniectomy often result in a residual scaphocephalic deformity, with a cephalic index ranging from 70 to 74, frequently below the population norm. 2, 5, 19, 29, 31, 47 Calvarial remodeling, by contrast, as a more extensive procedure allows a comprehensive correction of the deformity, which usually returns the cephalic index to the normal population mean. 15, 26, 40, 44 We do not believe that raised ICP can simply be attributed to a poor morphological outcome in a minority of cases in an otherwise successful procedure. In data we have presented elsewhere, we found that the preoperative and immediate postoperative head circumference and cephalic index of patients who developed an abnormal ICP were indistinguishable from other patients treated by the same technique.
Early restenosis of the sagittal suture has been implicated in the development of intracranial hypertension. 1, 3, 8 In our unit we do not perform serial radiological investigations in asymptomatic postoperative children, to minimize their radiation exposure. Therefore, we cannot comment as to whether early restenosis occurred in this series. However, a wide vertex strip was taken in the MSC technique employed, with the intention of preventing its occurrence. By the time patients were re-imaged, at least 18 months after surgery, it was typical to find new bone formation at previous osteotomy and craniectomy sites.
Over the last decade many craniofacial units have adopted minimal access, endoscopic, or spring-assisted approaches to correcting SC, in part in an attempt to avoid the morbidity and cost perceived to be associated with total CR techniques. 7, 10, 17, 18, 30, 37, 41, 48, 52 The incidence of postoperative intracranial hypertension with these procedures has yet to be reported. In broad terms, these approaches appear to result in better morphological outcomes than open vertex strip craniectomy procedures, with cephalic indices within the normal range. 7, 10, 18, 30, 37, 41 If the correction of the scaphocephalic deformity is an important determinant of the development of raised ICP, then one might expect these techniques to have a similar postoperative incidence to that we report for CR. However, we do not understand the mechanism by which intracranial hypertension arises in SC following surgery. Postoperative interventions that constrain cranial expansion following surgery, such as helmet therapy, might inadvertently increase the incidence of raised ICP.
In addition to the primary procedure, we also identified a relationship between age at primary surgery and the development of raised ICP postoperatively. Because of the close correlation between age at operation and surgical procedure (Fig. 3) we were unable to determine which factor of the two was more significant. However, in the MSC group, the age at operation of those who later developed raised ICP was essentially the same as those who did not, indicating that age is unlikely to be a significant factor within this group. Conversely, in the CR group the 2 patients who suffered raised ICP following surgery were both younger than the group mean and median, which does not discount the possibility that age might still be a significant factor with this procedure. Performing CR procedures in infants of a similar age to the MSC group would be likely to provide data that would resolve this question, although justifying doing so would be difficult.
During the latter part of the series presented here, our unit abandoned the MSC procedure because of a growing realization that reoperation rates were higher following MSC than CR, and that morphological outcomes were generally less satisfactory. In this study the MSC cohort had an overall major transcranial reoperation rate of 21.3%, including both ICP and morphological indications, as compared with a 1.6% rate for CR (excluding minor ICP monitoring procedures in both groups).
We accept that CR entails longer admissions and greater transfusion rates than MSC, 25 and is liable to a higher incidence of accidental vascular or dural breach, as is inevitable with the more extensive dissection that the procedure demands. However, we consider that it is undesirable to expose patients to a procedure, the MSC, which still has attendant risks, 25, 27 is less effective at correcting the scaphocephalic deformity, and has a markedly higher reoperation rate, with the risks that that entails. The significantly higher rate of raised ICP experienced by these patients postoperatively is a further cause of concern.
The question arises as to whether the 2 surgical cohorts presented here originate from the same population. In our estimation they do. The severity of disease, as measured by the cephalic index, is very similar between the 2 groups. Patient selection was strictly conducted to exclude all but those who had what was considered to be an isolated, nonsyndromic SC. In total 11 patients were excluded. Two had syndromes known to be associated with craniosynostosis, 4 had chromosomal abnormalities, 3 had mutations of genes associated with craniosynostosis, and 2 had sagittal synostosis secondary to intraventricular hemorrhage and CSF shunting. The only factor that separates the two groups, and decided which operation a child underwent, was the age at which they were first examined by the Unit. Variations in age at which primary healthcare teams make the initial diagnosis, and the efficacy of the referral route then pursued, inevitably occur with a relatively rare condition managed by a supraregional unit, such as in this situation. This study's data does not support the notion that more severe cases presented earlier and thus were more likely to undergo MSC.
conclusions
The overall rate of raised ICP following corrective surgery for SC was 6.9% in this series of 217 patients. This incidence was affected by age and surgical approach, with raised ICP significantly more common in patients treated by MSC, at an age of 9 months or younger (14.6%), rather than older children treated by CR (1.6%; p = 0.018). The onset of raised ICP following surgery was insidious. It was confirmed in patients on average over 4 years after surgery, but as late as more than 8 years afterward. Once it was suspected, clinical findings and radiological investigations did not reliably predict its presence. Therefore, patients who have been treated for SC should be enrolled in long-term follow-up regimens that actively screen for raised ICP.
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